Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Eric Siemers

Chief Medical Officer at Acumen Pharmaceuticals, Inc. (ABOS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $27K

Reported trades

Filed Stock Type Shares Price Value Since
Jan 23SEC ABOSAcumen Pharmaceuticals, Inc. Sell Plan 2,331256,266 held (−1%) $1.80 $4K -6.1%
Jan 23SEC ABOSAcumen Pharmaceuticals, Inc. Sell Plan 895255,371 held (−0%) $1.82 $2K -7.1%
Jan 7SEC ABOSAcumen Pharmaceuticals, Inc. Sell Plan 4,000166,298 held (−2%) $1.96 $8K -13.8%
Jan 7SEC ABOSAcumen Pharmaceuticals, Inc. Sell Plan 6,834159,464 held (−4%) $1.97 $13K -14.2%
  • Sell

    Chief Medical Officer Eric Siemers sold $4K of ABOS at $1.80 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Eric Siemers sold $2K of ABOS at $1.82 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Eric Siemers sold $8K of ABOS at $1.96 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Eric Siemers sold $13K of ABOS at $1.97 — pre-scheduled 10b5-1 plan sale.